Ann Coker to Give Presentation on Link Between Violence Against Women and Cancer
Ann Coker, professor in the University of Kentucky College of Medicine and Verizon Wireless Endowed Chair in the UK Center for Research on Violence Against Women (CRVAW), will host a presentation this Tuesday on the link between violence against women and cancer.
The presentation, titled “Violence against women and cancer incidence, care and recovery,” will be held at 8 a.m. Tuesday, Jan. 17, in room 263 of the Medical College Building (MC263).
Violence against women is defined as sexual assaults or sexual abuse during childhood, and intimate partner physical, sexual or psychological abuse.
Experimental Treatment for Parkinson's Symptoms Shows Early Promise
Laura Dawahare | UKnow | Jan. 6, 2017
Moliterno Named Editor of JACC: Cardiovascular Interventions
The American College of Cardiology has named Gill Heart Institute's Dr. David J. Moliterno, the new editor-in-chief of JACC: Cardiovascular Interventions.
Moliterno is the Jack M. Gill Chair and professor of the Department of Internal Medicine at the University of Kentucky. He is also a member of the interventional cardiology faculty at the UK Gill Heart Institute.
Cervical Cancer is Preventable, but Still Leading Cancer in Kentucky
At the beginning of the year, many women (and men) set resolutions around health and fitness, often focusing on weight loss. But one of the most important habits women can form revolves around regular health checks, particularly for preventable cancers.
January is cervical cancer awareness month. Unfortunately, Kentucky ranks in the top 10 in the country for cervical cancer incidence and death rates – a dire statistic considering cervical cancer is largely preventable through vaccination and screening.
The human papillomavirus (HPV) causes virtually all cases of cervical carcinomas.
New Study Shows Promise for Repurposing Anti-Malarial Drug for Cancer Treatment
A new study by University of Kentucky Markey Cancer Center researchers shows that chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers.
Published in Cell Reports, the study showed that chloroquine induced the secretion of the tumor suppressor protein Par-4 in both mouse models and in cancer patients in a clinical trial.
VPR Office Announces Equipment Competition
[from the VPR's Office]
University of Kentucky
Office of the Vice President for Research Equipment Competition
New Font Guidelines for NIH Grant Applications
For applications submitted for due dates on or after January 25, 2017, text in PDF attachments must follow these minimum requirements:
NIH Releases New Administrative Supplement Opportunities
Check out Newly Issued NIH Administrative Supplement Opportunities!
Although the continuing resolution for funding of the FY 2017 federal budget has been extended to spring, potentially delaying issuance of some awards or temporarily reducing current year budget amounts, the National Institutes of Health (NIH) has issued a number of opportunities for supplemental funding to an array of active awards across diverse grant mechanisms.